GlassScriptPhysician profile
Ashley C Walker
NPI 1093155111
$906.95
in general payments reported to CMS, 2019-2025
12 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.27 · 2020: $33.99 · 2021: $55.24 · 2022: $77.17 · 2023: $97.94 · 2024: $168 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $499.28 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $159.78 | 2021-2025 | Qulipta |
| Lilly USA, LLC | $59.42 | 2021-2025 | Mounjaro, Zepbound |
| Dexcom, INC. | $45.42 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $26.59 | 2019-2021 | |
| Axsome Therapeutics, INC. | $21.38 | 2025 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $18.72 | 2024 | Airsupra |
| Allergan, INC. | $16.50 | 2020 | |
| Pfizer INC. | $15.20 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.13 | 2024 | Trintellix |
| Corium, LLC | $15.06 | 2023 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.47 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.